![Icon depicting a video play button](https://biologics.catalent.com/wp-content/uploads/sites/2/2023/03/video.png)
iPSCs, a Universal Starting Material for Cell Therapies
Summary: iPSCs are a critical starting material and enable the availability of next-generation cell therapies for broad patient populations. Learn more about Catalent’s GMP iPSC capabilities including reprogramming, differentiation, and cell banking, and how they can create a path to make cell therapies more accessible.